bioMérieux
The Power of In Vitro Diagnostics in Fighting Infectious Diseases
Rapid identification, targeted action.
bioMérieux has been committed to serving public health for more than 60 years. With operations in 45 countries, the company is one of the global leaders in in vitro diagnostics for clinical and industrial applications. Its solutions help improve patient health and protect consumer safety.
Two complementary areas of expertise:
- Clinical diagnostics: identification of infection-causing micro-organisms and antimicrobial resistance to guide patient care. These solutions are used in hospital and private labs, and sometimes directly in emergency rooms and doctors’ offices.
- Safety and quality – industrial sector: a range of solutions that benefit patients and consumers by helping industry players ensure the quality and safety of food products, pharmaceuticals and cosmetics.
“Diagnostics are our first line of defense against infections. They guide medical decisions, help preserve the effectiveness of antibiotics, and ensure the quality of food and pharmaceutical products.”
15,000
employees
M€ 4,070
annual revenue for 2025